Editing the Epigenome: Treating Disease by Rewriting Gene Expression, Not the Genome

A new wave of biotechnology focuses on epigenome editing—altering chemical marks that control how genes are turned on or off—to treat or prevent disease later in life without changing the underlying DNA. By mimicking natural resets of epigenetic marks, researchers aim to rewrite the “nurture” of gene activity rather than the “nature” of the genetic code. Early results in cells and animals are promising, but major challenges remain in delivery, specificity, safety, and long-term effects, alongside ethical and regulatory considerations.